Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Sector Update: Healthcare

Sector Update: Healthcare

MT newswireMT newswire2026/10/21 16:58
12:58 PM EDT, 10/21/2026 (MT Newswires) -- Healthcare stocks declined Wednesday afternoon, with the NYSE Healthcare Index down 0.7% and the State Street Health Care Select Sector SPDR ETF (XLV) falling 1%. The iShares Biotechnology ETF (IBB) rose 0.6%. In corporate news, Abbott Laboratories (ABT) said Wednesday it plans to separate its Nutrition business into an independent, publicly traded company with about $8.5 billion in annual sales. Separately, Abbott reported Q3 adjusted EPS Wednesday of $1.42, up from $1.30 a year earlier and matching the FactSet consensus. Abbott shares were down 3.9%.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

South Korea’s current account surplus in September exceeded 60 billions USD for the first time, with semiconductor exports becoming the main driver

Driven by booming semiconductor exports, South Korea's current account surplus in September surged to a record high.

智通财经•2026/11/05 02:41
South Korea’s current account surplus in September exceeded 60 billions USD for the first time, with semiconductor exports becoming the main driver

CoreWeave (CRWV.US) bonds hit a new low as changes in Texas data center policies impact AI cloud trading

CoreWeave (CRWV.US) bonds fell sharply on Wednesday, with some dropping to new lows.

智通财经•2026/11/05 01:51
CoreWeave (CRWV.US) bonds hit a new low as changes in Texas data center policies impact AI cloud trading

AstraZeneca (AZN.US) reportedly receives a $10 billion acquisition offer! Shares of obesity drug developer Rhythm (RYTM.US) soar in response

According to three people familiar with the matter, AstraZeneca previously proposed to acquire obesity drug developer Rhythm Pharmaceuticals for approximately 10 billion dollars.

智通财经•2026/11/05 01:36